Combined Administration of Nitric Oxide and Hydrogen into Extracorporeal Circuit of Cardiopulmonary Bypass as a Method of Organ Protection during Cardiac Surgery
The aim is to study the effect of combined introduction of nitric oxide and hydrogen into the extracorporeal circuit of cardiopulmonary bypass (CPB) for antioxidant activity and organ damage during cardiac surgery.
Materials and Methods. The study included 91 patients who underwent heart surgery under CPB. The patients were randomized into 3 groups: group 1 comprised 30 patients (control); group 2 consisted of 33 patients with an isolated supply of nitric oxide (40 ppm) to the extracorporeal circuit; group 3 included 28 patients with a combined supply of nitric oxide (40 ppm) and hydrogen (1.2 ppm) into the extracorporeal circuit. The intensity of lipid peroxidation processes was studied by the content of diene conjugates (DC), triene conjugates (TC), Schiff bases (SB) in blood plasma; erythrocyte aggregation was also examined. The studies were carried out at the following stages: stage 1 (initial) — after induction of anesthesia; stage 2 — before CPB; stage 3 — 5 min after CPB initiation; stage 4 — at the 30th minute of CPB; stage 5 — at the 60th minute of CPB; stage 6 — at the 90th minute of CPB; stage 7 — at CPB termination; stage 8 — at the end of the operation.
Results. The content of DC increased statistically significantly at the 90th minute of CPB to 1.093±0.573 rel. units (M±SD) in patients of group 1; to 0.322±0.047 rel. units in group 2; to 0.287±0.003 rel. units in group 3, while the DC content was statistically significantly lower in patients of groups 2 and 3 compared to group 1. A statistically significant increase in the content of TC compared to the initial value was observed at the 90th minute of CPB in group 1 (up to 0.334±0.114 rel. units), while the content of TC was statistically significantly lower in patients of groups 2 and 3. A statistically significant growth in the content of SB occurred at the 90th minute of CPB in patients of group 1 up to 33.324±15.640 rel. units. This indicator was statistically significantly lower in groups 2 and 3 relative to the patients of group 1. The dynamics of erythrocyte aggregation in patients of group 1 showed statistically significant growth of this indicator from the start of CPB to the end of the operation (from 44.8±1.4 to 73.1±2.2%). The statistically significant difference from the indicator at the beginning of the operation started at the 30th minute of CPB and lasted until the end of the operation. In patients of group 2, it decreased statistically significantly during CPB (from 56.5±2.3% before the CPB initiation to 47.4±1.2% at the CPB termination); in patients of group 3, it was decreasing from the 60th minute of CPB to the end of the operation and was statistically significantly lower than in patients of both groups 1 and 2. No postoperative complications were noted (acute heart failure, acute respiratory failure, multiple organ failure) in patients of groups 2 and 3. A statistically significant decrease in both the duration of mechanical ventilation and stay in the intensive care unit was registered in group 3 compared to group 2.
Conclusion. The combined use of gaseous nitric oxide and hydrogen during CPB allowed a statistically significant decrease in the level of activation of lipid peroxidation and erythrocyte aggregation, which ensured a higher level of organ protection during cardiac surgery, faster activation of patients, and a shorter stay in the intensive care unit.
- Charnaia M.A., Morozov Iu.A., Uriuzhnikov V.V., Goncharova A.V., Paliulina M.V. Myocardial metabolism in operations under parallel artificial circulation. Kardiologiya i serdechno-sosudistaya khirurgiya 2012; 5(3): 68–70.
- Andrianova M.Yu., Palyulina M.V., Morozov Yu.A., Mil’chakov V.I., Charnaya M.A., Gladysheva V.G. Lipid peroxidation in the early postoperative period during reconstructive operations on the aorta. Vestnik intensivnoj terapii 2007; 1: 76–77.
- Zatsepina N.E. Vliyanie iskusstvennogo krovoobrashcheniya na perekisnoe okislenie lipidov. Avtoref. dis. ... kand. med. nauk [Influence of cardiopulmonary bypass on lipid peroxidation. PhD Thesis]. Moscow; 2001.
- Bilenko M.V. Ishemicheskie i reperfuzionnye povrezhdeniya organov (molekulyarnye mekhanizmy, puti preduprezhdeniya i lecheniya) [Ischemic and reperfusion injuries of organs (molecular mechanisms, ways of prevention and treatment)]. Moscow: Meditsina; 1989; p. 368.
- Garden D.L., Granger D.N. Pathophysiology of ischaemia-reperfusion injury. J Pathology 2000; 190(3): 255–266, https://doi.org/10.1002/(sici)1096-9896 (200002)190:3255::aid-path5263.0.co;2-6.
- Manso C.F. Ischemia, reperfusion and oxygen free radicals. Rev Port Cardiol 1992; 11(11): 997–998.
- Prasad K., Kalra J., Bharadwaj B., Chaudhary A.K. Increased oxygen free radical activity in patients on cardiopulmonary bypass undergoing aortocoronary bypass surgery. Am Heart J 1992; 123(1): 37–45, https://doi.org/10.1016/0002-8703(92)90744-g.
- Asimakopoulos G., Smith P.L., Ratnatunga C.P., Taylor K.M. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg 1999; 68(3): 1107–1115, https://doi.org/10.1016/s0003-4975(99)00781-x.
- Solovieva A.G., Kuznetsova V.L., Peretyagin S.P., Didenko N.V., Dudar A.I. Role of nitric oxide in processes of free radical oxidation. Vestnik Rossijskoj Voenno-medicinskoj akademii 2016; 1: 228–233.
- Danilova D.A., Brichkin Yu.D., Medvedev A.P., Pichugin V.V., Fedorov S.A., Taranov E.V., Nazarov E.I., Ryazanov M.V., Bolshukhin G.V., Deryugina A.V. Application of molecular hydrogen in heart surgery under cardiopulmonary bypass. Sovremennye tehnologii v medicine 2021; 13(1): 71, https://doi.org/10.17691/stm2021.13.1.09.
- Deryugina A.V., Krylova E.V., Luk’yanova L.D. Effect of ubiquinone-10 and succinic acid on functional characteristics of erythrocytes in rats with epinephrine toxemia. Bull Exp Biol Med 2006; 141: 414–415, https://doi.org/10.1007/s10517-006-0186-0.
- Olejnik S., Algina J. Generalized eta and omega squared statistics: measures of effect size for some common research designs. Psychological Methods 2003; 8(4): 434–447, https://doi.org/10.1037/1082-989X.8.4.434.
- Checchia P.A., Bronicki R.A., Muenzer J.T., Dixon D., Raithel S., Gandhi S.K., Huddleston C.B. Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children — a randomized trial. J Thorac Cardiovasc Surg 2013; 146(3): 530–536, https://doi.org/10.1016/j.jtcvs.2012.09.100.
- James C., Millar J., Horton S., Brizard C., Molesworth C., Butt W. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med 2016; 42(11): 1744–1752, https://doi.org/10.1007/s00134-016-4420-6.
- Kamenshchikov N.O., Mandel I.A., Podoksenov Y.K., Svirko Y.S., Lomivorotov V.V., Mikheev S.L., Kozlov B.N., Shipulin V.M., Nenakhova A.A., Anfinogenova Y.J. Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: randomized trial. J Thorac Cardiovasc Surg 2019; 157(6): 2328–2336.e1, https://doi.org/10.1016/j.jtcvs.2018.08.117.
- Deryugina A.V., Danilova D.A., Brichkin Yu.D., Nazarov E.I., Medvedev A.P., Pichugin V.V., Makarov E.V., Taranov E.V., Fedorov S.A., Ivashchenko M.N. Possibilities of correcting the oxygen transport function of erythrocytes in cardiac surgery patients during operations with cardiopulmonary bypass. Bioradikaly i antioksidanty 2020; 7(3): 155–162.